Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

1.

Early mortality and functional outcome after acute stroke in Uganda: prospective study with 30 day follow-up.

Nakibuuka J, Sajatovic M, Nankabirwa J, Ssendikadiwa C, Furlan AJ, Katabira E, Kayima J, Kalema N, Byakika-Tusiime J, Ddumba E.

Springerplus. 2015 Aug 25;4:450. doi: 10.1186/s40064-015-1252-8. eCollection 2015.

PMID:
26322256
2.

The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural Models.

Ford D, Robins JM, Petersen ML, Gibb DM, Gilks CF, Mugyenyi P, Grosskurth H, Hakim J, Katabira E, Babiker AG, Walker AS; DART Trial Team.

Am J Epidemiol. 2015 Aug 26. pii: kwv083. [Epub ahead of print]

PMID:
26316598
3.

The Vancouver Consensus: antiretroviral medicines, medical evidence, and political will.

Beyrer C, Birx DL, Bekker LG, Barré-Sinoussi F, Cahn P, Dybul MR, Eholié SP, Kavanagh MM, Katabira ET, Lundgren JD, Mworeko L, Pala M, Puttanakit T, Ryan O, Sidibé M, Montaner JS; Vancouver Consensus Signatories.

Lancet. 2015 Aug 8;386(9993):505-7. doi: 10.1016/S0140-6736(15)61458-1. No abstract available.

PMID:
26293427
4.

Perceptions of epilepsy among first-year medical students at Mulago Hospital in Kampala, Uganda.

Bigelow J, Berrett S, Kimuli I, Katabira E.

Epilepsy Behav. 2015 Aug 4;51:28-32. doi: 10.1016/j.yebeh.2015.06.020. [Epub ahead of print]

PMID:
26253598
5.

Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda.

Ying R, Sharma M, Heffron R, Celum CL, Baeten JM, Katabira E, Bulya N, Barnabas RV.

J Int AIDS Soc. 2015 Jul 20;18(4 Suppl 3):20013. doi: 10.7448/IAS.18.4.20013. eCollection 2015.

6.

Stroke-Risk Factors Differ between Rural and Urban Communities: Population Survey in Central Uganda.

Nakibuuka J, Sajatovic M, Nankabirwa J, Furlan AJ, Kayima J, Ddumba E, Katabira E, Byakika-Tusiime J.

Neuroepidemiology. 2015;44(3):156-65. doi: 10.1159/000381453. Epub 2015 May 7.

PMID:
25967045
7.

Parasite Specific Antibody Increase Induced by an Episode of Acute P. falciparum Uncomplicated Malaria.

Kaddumukasa M, Lwanira C, Lugaajju A, Katabira E, Persson KE, Wahlgren M, Kironde F.

PLoS One. 2015 Apr 23;10(4):e0124297. doi: 10.1371/journal.pone.0124297. eCollection 2015.

8.

A novel symptom cluster analysis among ambulatory HIV/AIDS patients in Uganda.

Namisango E, Harding R, Katabira ET, Siegert RJ, Powell RA, Atuhaire L, Moens K, Taylor S.

AIDS Care. 2015;27(8):954-63. doi: 10.1080/09540121.2015.1020749. Epub 2015 Mar 18.

PMID:
25782972
9.

Enabling dynamic partnerships through joint degrees between low- and high-income countries for capacity development in global health research: experience from the Karolinska Institutet/Makerere University partnership.

Sewankambo N, Tumwine JK, Tomson G, Obua C, Bwanga F, Waiswa P, Katabira E, Akuffo H, Persson K, Peterson S.

PLoS Med. 2015 Feb 3;12(2):e1001784. doi: 10.1371/journal.pmed.1001784. eCollection 2015 Feb. No abstract available. Erratum in: PLoS Med. 2015 Mar;12(3):e1001816. Persson, Kristina [corrected to Persson, Kristina E M].

10.

Integration of antenatal syphilis screening in an urban HIV clinic: a feasibility study.

Manabe YC, Namale G, Nalintya E, Sempa J, Ratanshi RP, Pakker N, Katabira E.

BMC Infect Dis. 2015 Jan 13;15:15. doi: 10.1186/s12879-014-0739-1.

11.

Global medical education partnerships to expand specialty expertise: a case report on building neurology clinical and research capacity.

Kaddumukasa M, Katabira E, Salata RA, Costa MA, Ddumba E, Furlan A, Kakooza-Mwesige A, Kamya MR, Kayima J, Longenecker CT, Mayanja-Kizza H, Mondo C, Moore S, Pundik S, Sewankambo N, Simon DI, Smyth KA, Sajatovic M.

Hum Resour Health. 2014 Dec 30;12(1):75. [Epub ahead of print]

12.

Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons.

Pattacini L, Murnane PM, Baeten JM, Fluharty TR, Thomas KK, Bukusi E, Katabira E, Mugo N, Donnell D, Lingappa JR, Celum C, Marzinke M, McElrath MJ, Lund JM; Partners PrEP Study Team.

J Infect Dis. 2015 Jun 15;211(12):1943-52. doi: 10.1093/infdis/jiu815. Epub 2014 Dec 17.

PMID:
25520426
13.

Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples.

Kahle EM, Bolton M, Hughes JP, Donnell D, Celum C, Lingappa JR, Ronald A, Cohen CR, de Bruyn G, Fong Y, Katabira E, McElrath MJ, Baeten JM; Partners in Prevention HSV/HIV Transmission Study Team.

J Infect Dis. 2015 May 1;211(9):1451-60. doi: 10.1093/infdis/jiu621. Epub 2014 Nov 10.

PMID:
25389306
14.

Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study.

Gomo ZA, Hakim JG, Walker SA, Tinago W, Mandozana G, Kityo C, Munderi P, Katabira E, Reid A, Gibb DM, Gilks CF; DART Team.

AIDS Res Ther. 2014 Oct 2;11(1):32. doi: 10.1186/1742-6405-11-32. eCollection 2014.

15.

Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial.

Baeten JM, Donnell D, Mugo NR, Ndase P, Thomas KK, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kidoguchi L, Coombs RW, Hendrix C, Marzinke MA, Frenkel L, Haberer JE, Bangsberg D, Celum C; Partners PrEP Study Team.

Lancet Infect Dis. 2014 Nov;14(11):1055-64. doi: 10.1016/S1473-3099(14)70937-5. Epub 2014 Oct 7.

PMID:
25300863
16.

Knowledge and Perception of Stroke: A Population-Based Survey in Uganda.

Nakibuuka J, Sajatovic M, Katabira E, Ddumba E, Byakika-Tusiime J, Furlan AJ.

ISRN Stroke. 2014;2014. doi: 10.1155/2014/309106.

17.

The Lablite project: a cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe.

Chan AK, Ford D, Namata H, Muzambi M, Nkhata MJ, Abongomera G, Mambule I, South A, Revill P, Grundy C, Mabugu T, Chiwaula L, Cataldo F, Hakim J, Seeley J, Kityo C, Reid A, Katabira E, Sodhi S, Gilks CF, Gibb DM; Lablite Team.

BMC Health Serv Res. 2014 Aug 19;14:352. doi: 10.1186/1472-6963-14-352.

18.

An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda.

Psaros C, Haberer JE, Katabira E, Ronald A, Tumwesigye E, Campbell JD, Wangisi J, Mugwanya K, Kintu A, Enyakoit M, Thomas KK, Donnell D, Krows M, Kidoguchi L, Ware N, Baeten JM, Celum C, Bangsberg DR, Safren SA.

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):522-9. doi: 10.1097/QAI.0000000000000212.

19.

Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the partners PrEP study experience.

Ndase P, Celum C, Campbell J, Bukusi E, Kiarie J, Katabira E, Mugo N, Tumwesigye E, Wangisi J, Were E, Brantley J, Donnell D, Baeten JM.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):206-12. doi: 10.1097/QAI.0000000000000141.

PMID:
24828268
20.

Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships.

Mujugira A, Celum C, Thomas KK, Farquhar C, Mugo N, Katabira E, Bukusi EA, Tumwesigye E, Baeten JM; Partners PrEP Study Team.

J Acquir Immune Defic Syndr. 2014 Aug 1;66(4):436-42. doi: 10.1097/QAI.0000000000000192.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk